C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2011
10/18/2011	CA2252986C Process for preparing functional recombinant tissue factor
10/18/2011	CA2232237C Reagents and methods useful for detecting diseases of the breast
10/13/2011	WO2011127426A1 Methods for modeling protein stability
10/13/2011	WO2011127418A1 Btnl9 proteins, nucleic acids, and antibodies and uses thereof
10/13/2011	WO2011127316A1 Method for generating a parvovirus b19 virus-like particle
10/13/2011	WO2011126976A1 Reovirus vaccines and methods of use therefor
10/13/2011	WO2011126897A2 Methods for enhancing by-products from fermentation processes
10/13/2011	WO2011126882A2 Therapeutic peptides and their derivatives and therapeutic uses thereof
10/13/2011	WO2011126863A1 Factor h binding proteins (fhbp) with altered properties and methods of use thereof
10/13/2011	WO2011126811A2 High level expression of recombinant toxin proteins
10/13/2011	WO2011126790A1 Methods and compositions for inducing brown adipogenesis
10/13/2011	WO2011126644A2 Plant peptide gamma-zein for delivery of biomolecules into plant cells
10/13/2011	WO2011126576A2 Genetic signatures in the envelope glycoprotein of hiv-1
10/13/2011	WO2011126370A1 Recombinant multimeric influenza proteins
10/13/2011	WO2011126174A1 Preparation method of curly amyloid fibrils derived from alpha-synuclein, preparation method of hydrogel using same, and using method thereof
10/13/2011	WO2011126054A1 Physiologically active peptides
10/13/2011	WO2011125872A1 Reagent for assaying anti-treponema pallidum antibody
10/13/2011	WO2011125860A1 Method for culturing cells in system containing laminin-5
10/13/2011	WO2011125748A1 Polynucleotides encoding nf-yb originating in jatropha and utilization thereof
10/13/2011	WO2011125139A1 Cluap1 peptides and vaccines including the same
10/13/2011	WO2011125034A1 Preparation of recombinant human plasma phospholipid transfer protein (pltp) from the milk of transgenic animals
10/13/2011	WO2011125015A2 Protease-activatable pore-forming polypeptides
10/13/2011	WO2011124925A2 Enzymes
10/13/2011	WO2011124718A1 Albumin derivatives and variants
10/13/2011	WO2011124685A1 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
10/13/2011	WO2011124463A1 Method for the production of sweet proteins
10/13/2011	WO2011123903A1 Chemokine receptor heteromultimers, compounds that bind thereto and uses thereof
10/13/2011	WO2011089250A3 Stable growth hormone compounds
10/13/2011	WO2011080078A3 Thermostable xylanase for the selective hydrolysis of pentose-containing polysaccharides
10/13/2011	WO2011067758A3 Immunogenic fragments and multimers from streptococcus pneumoniae proteins
10/13/2011	WO2011064779A3 Peptides derived from hiv-1 gp41 transmembrane for t - immunomodulation
10/13/2011	WO2011063235A3 Peptides, devices, and methods for the detection of ehrlichia antibodies
10/13/2011	WO2011049350A3 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
10/13/2011	WO2011046996A3 Consensus sequence for influenza a virus
10/13/2011	WO2011023816A3 Peptides of cenp-a and use thereof
10/13/2011	WO2010103284A8 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene
10/13/2011	WO2010099394A9 Alteration and modulation of protein activity by varying post-translational modification
10/13/2011	US20110252509 Method for Producing a Transgenic Cell with Increased Gamma-Aminobutyric Acid (Gaba) Content
10/13/2011	US20110252498 Soybean Cultivar 1000679
10/13/2011	US20110252497 Soybean Cultivar S090244
10/13/2011	US20110252496 Soybean Cultivar 86237173
10/13/2011	US20110252495 Soybean Cultivar 89126133
10/13/2011	US20110252494 Soybean Cultivar S090247
10/13/2011	US20110252492 Soybean cultivar 8029288
10/13/2011	US20110252489 Method of identifying prolificacy in mammals
10/13/2011	US20110251486 Radiolabeled annexins
10/13/2011	US20110251376 Mammalian Tumor Susceptibility Genes and their Uses
10/13/2011	US20110251267 Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factor
10/13/2011	US20110251127 Inactivation of infectious agents in plasma proteins by extreme pressure
10/13/2011	US20110251120 Antimicrobial Peptides and Methods of Identifying the Same
10/13/2011	US20110251095 Mara family helix-turn-helix domains and their methods of use
10/13/2011	US20110250702 Isolated peptides of rabbit factor vii
10/13/2011	US20110250693 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
10/13/2011	US20110250670 Light energy-induced stability of biomaterials
10/13/2011	US20110250650 Lentiviral vectors for the preparation of immunotherapeutical compositions
10/13/2011	US20110250641 Zwitterionic acid-labile surfactants and methods of use
10/13/2011	US20110250638 Lignocellulosic biomass conversion
10/13/2011	US20110250630 Motif-grafted hybrid polypeptides and uses thereof
10/13/2011	US20110250623 Biomarker and method for detecting a chronic inflammatory-associated disease
10/13/2011	US20110250615 Methods and Compositions for Detection of Ehrlichia chaffeensis (VLPT)
10/13/2011	US20110250613 Arrayed Multiple Ubiquitin Binding Domains as Linkage-specific Polyubiquitin Affinity Reagents
10/13/2011	US20110250612 Novel centromeric protein shugoshin
10/13/2011	US20110250596 Methods, kits and compositions pertaining to linear beacons
10/13/2011	US20110250345 Soybean Cultivar S090252
10/13/2011	US20110250342 PUFA Polyketide Synthase Systems and Uses Thereof
10/13/2011	US20110250310 Whey protein compositions, methods and uses
10/13/2011	US20110250234 Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof
10/13/2011	US20110250232 DNA-Transfection System for the Generation of Infectious Influenza Virus
10/13/2011	US20110250223 Hybrid and tandem expression of neisserial proteins
10/13/2011	US20110250222 Antigenic polypeptides of chlamydia-related bacteria for diagnosis and vaccine
10/13/2011	US20110250221 Group A Streptococcus Pharmaceutical Compositions and Methods Thereof
10/13/2011	US20110250220 Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric complexes, and uses thereof
10/13/2011	US20110250218 Disease-Associated Antigens and Methods of Use Thereof
10/13/2011	US20110250213 Antibodies to cd122
10/13/2011	US20110250208 Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor
10/13/2011	US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
10/13/2011	US20110250199 Immunotoxins and uses thereof
10/13/2011	US20110250198 ActRIIB FUSION POLYPEPTIDES AND USES THEREFOR
10/13/2011	US20110250177 Alpha interferon variants
10/13/2011	US20110250169 Derivatives of growth hormone and related proteins
10/13/2011	DE102010016387A1 Verfahren zur Herstellung süßer Proteine Process for the preparation of sweet proteins
10/13/2011	CA2796012A1 Preparation of recombinant human plasma phospholipid transfer protein (pltp) from the milk of transgenic animals
10/13/2011	CA2795789A1 Btnl9 proteins, nucleic acids, and antibodies and uses thereof
10/13/2011	CA2795423A1 Cluap1 peptides and vaccines including the same
10/13/2011	CA2795390A1 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
10/13/2011	CA2795031A1 Method for culturing cells in a system comprising laminin-5
10/13/2011	CA2794710A1 Reagent for assaying anti-treponema pallidum antibody
10/13/2011	CA2794082A1 Plant peptide gamma-zein for delivery of biomolecules into plant cells
10/13/2011	CA2793978A1 High level expression of recombinant toxin proteins
10/13/2011	CA2790167A1 Factor h binding proteins (fhbp) with altered properties and methods of use thereof
10/12/2011	EP2374894A2 A method for producing influenza hemagglutinin multivalent vaccines
10/12/2011	EP2374891A2 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system
10/12/2011	EP2374889A2 Novel compounds
10/12/2011	EP2374888A1 Method for producing human recombinant insulin
10/12/2011	EP2374883A1 Anti-cd4 antibody
10/12/2011	EP2374877A2 Polypeptides having endoglucanase activity and polynucleotides encoding same
10/12/2011	EP2374876A2 Therapy for alpha-galactosidase a deficiency
10/12/2011	EP2374872A2 A method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
10/12/2011	EP2374870A2 Use of OP-1 for the preparation of a pharmaceutical composition for reparing a defect locus in a non articular cartilage tissue of a mammal
10/12/2011	EP2374815A1 Canine CD20 compositions

1 ... 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 ... 2916